HopeStage
Back to all studies
WithdrawnNCT03895658

Title: Safety and Feasibility of Individualized Low Amplitude Seizure Therapy (iLAST)

Device studyAges 22–70United StatesDepression
The study in practice

Understand this study

Who could participate?

Listed age limits: 22 years to 70 years.

Listed locations
BethesdaSee all locations and recruitment
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: February 26, 2025
Recruitment status
Withdrawn
Enrollment listed in the registry
0
Sponsor
National Institute of Mental Health (NIMH)
Sponsor type
Government agency
Study type
Device
Intervention type
Device
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Locations
United States
Age range
From 22 Years to 70 Years
Official registry ID
NCT03895658
Official title
Show the full official title

Safety and Feasibility of Individualized Low Amplitude Seizure Therapy (iLAST)

Recruitment & locations

Withdrawn

Bethesda

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is National Institute of Mental Health (NIMH), a government agency.

Who can participate?

Listed age limits: 22 years to 70 years.

Is this study still recruiting?

The registry lists this study as withdrawn.

Want to explore more studies?

Explore studies